Performance Stack
GH-Axis Performance Stack.
Three classic growth-hormone secretagogues — CJC-1295 + Ipamorelin synergy blend, Sermorelin and Tesamorelin — structured as one bundle for GH-axis and IGF-1 research positioning.
Fresh-batch only — per-batch COA included with every shipment.
Why It Works
Built for the fastest GH-axis research decision.
GHRH-class angle
CJC-1295 and Sermorelin act on the GHRH receptor — the standard secretagogue mechanism in published GH-pulse research.
GHRP-class angle
Ipamorelin pairs with CJC-1295 for the canonical GHRH/GHRP synergy literature — selective ghrelin-receptor agonism.
Visceral-fat angle
Tesamorelin is the only stabilised GHRH analog with an FDA-approved indication, and the most-cited compound for visceral-adipose research.
Stack Composition
The three compounds anchoring the offer.
Each compound is available standalone in the shop — the stack bundles them at flagship positioning.
Performance
CJC-1295 + Ipamorelin
Canonical GHRH + GHRP synergy blend. The most-cited GH-pulse research configuration.
Performance
Sermorelin
29-amino-acid GHRH(1-29) analog. The reference GHRH compound in early GH-axis literature.
Performance
Tesamorelin
Stabilised GHRH analog. The most-studied compound for visceral-adipose-tissue research.
Bundles
Choose the stack that matches your intensity.
Pick the tier that fits, then confirm below. One decision point, one clean checkout.
Trust
Built to remove friction before the buy decision.
Lab-grade positioning
Clean sourcing, limited-run batches, consistent purity across every restock.
Discreet EU shipping
Neutral packaging, tracked dispatch, fast transit across the EU.
Secure checkout
Mollie PCI-DSS infrastructure. No card data touches this site.
Research-use positioning
Products presented strictly for laboratory research. No medical claims.
FAQ
Clear answers remove hesitation.
Which performance tier fits me?
Starter (CJC-1295+Ipa alone) for the canonical synergy entry. Advanced adds Sermorelin for the reference GHRH compound. Ultimate adds Tesamorelin for the visceral-fat angle.
Why these three compounds?
CJC-1295 + Ipamorelin is the canonical GHRH/GHRP synergy pair in the literature. Sermorelin is the reference GHRH(1-29) compound. Tesamorelin is the only stabilised GHRH with a visceral-adipose-tissue indication.
How does shipping work?
Tracked dispatch with neutral, discreet packaging. Fresh-batch model: 14–21 days transit, per-batch COA included.
Decision Layer
Choose your stack and move now.
The biggest conversion killer is hesitation. Pick the tier that fits, confirm research use, check out.
Research library
Read the research behind the stack.
Long-form research-frame deep-dives on each of the three GHRH/GHRP compounds anchoring this stack — the canonical synergy blend, the reference GHRH analog, and the stabilised visceral-adipose-research compound.
Deep-dive · 14 min
CJC-1295 + Ipamorelin guide
Canonical GHRH/GHRP synergy pair — DAC-extended GHRH analog + selective ghrelin-receptor agonist. Dual-pathway GH-pulse research.
Deep-dive · 13 min
Sermorelin complete guide
Reference GHRH(1-29) analog — pituitary GHRH-receptor binding, pulsatile GH release, IGF-1 axis, somatopause research.
Deep-dive · 13 min
Tesamorelin complete guide
Stabilised GHRH analog — structure, half-life, FDA-approved indication, visceral-adipose-tissue research corpus.